Joseph Chang
Dr. Joseph Y. Chang, chief scientific officer at Nu Skin Enterprises Inc., Provo, recently received an award for outstanding contributions in personalized nutrition from the University of California-Davis’ Department of Nutrition. He received the honor after delivering the 16th annual Kosuna Distinguished Lecture in Nutrition at the university. The award is presented for extraordinary achievements and contributions to nutritional science. Chang has 35 years of experience in the pharmaceutical and dietary supplement industries and was appointed chief scientific officer and executive vice president of product development at Nu Skin in 2006. Before the acquisition of Pharmanex by Nu Skin Enterprises in 1998, Chang served as the vice president of clinical studies and pharmacology at Pharmanex. Before that, he was president and chief scientific officer of Osteoarthritis Sciences Inc. and Binary Therapeutics Inc. and has held various research management positions at Wyeth-Ayerst, Rhone Poulenc Rorer and other biotechnology companies.
